Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Heimbrook

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1995
Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancerM R Goldberg, D C Heimbrook, P Russo, et al.
The Journal of Biological Chemistry|August 5, 1990
Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor proteinR E Jones, R J Wegrzyn, D R Patrick, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1990
Transforming growth factor alpha-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenograftsD C Heimbrook, S M Stirdivant, J D Ahern, et al.
Biochemistry|February 10, 1987
Copper-dependent cleavage of DNA by bleomycinG M Ehrenfeld, J B Shipley, D C Heimbrook, et al.
The Journal of Biological Chemistry|March 29, 2001
Anions modulate the potency of geranylgeranyl-protein transferase I inhibitorsH E Huber, R G Robinson, A Watkins, et al.
Cancer Research|December 26, 2001
Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical modelsR B Lobell, C A Omer, M T Abrams, et al.
Journal of Medicinal Chemistry|August 25, 2001
Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potencyI M Bell, S N Gallicchio, M Abrams, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1995
Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancerM R Goldberg, D C Heimbrook, P Russo, et al.
The Journal of Biological Chemistry|August 5, 1990
Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor proteinR E Jones, R J Wegrzyn, D R Patrick, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1990
Transforming growth factor alpha-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenograftsD C Heimbrook, S M Stirdivant, J D Ahern, et al.
Biochemistry|February 10, 1987
Copper-dependent cleavage of DNA by bleomycinG M Ehrenfeld, J B Shipley, D C Heimbrook, et al.
The Journal of Biological Chemistry|March 29, 2001
Anions modulate the potency of geranylgeranyl-protein transferase I inhibitorsH E Huber, R G Robinson, A Watkins, et al.
Cancer Research|December 26, 2001
Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical modelsR B Lobell, C A Omer, M T Abrams, et al.
Journal of Medicinal Chemistry|August 25, 2001
Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potencyI M Bell, S N Gallicchio, M Abrams, et al.
Pageof 4